Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews. https://t.co/yXfYLFDIZY
Revue Cochrane sur l’utilisation des corticostéroïdes chez les nouveau-nés atteints de dysplasie bronchopulmonaire. https://t.co/EjHdBUBtyO #pédiatrie #néonatologie https://t.co/UkhQffUNje
🌟NEW RESEARCH🌟 What are the benefits and risks of treating preterm infants at risk of developing bronchopulmonary dysplasia with corticosteroids? 🤓 Check out the research here: https://t.co/sEL9xKa9Gj #preterm #infants #healthinterventions @tewhatuora
RT @jramonfernandez: La dexametasona administrada a partir del séptimo día de vida se considera una intervención eficaz y segura para reduc…
RT @jramonfernandez: La dexametasona administrada a partir del séptimo día de vida se considera una intervención eficaz y segura para reduc…
RT @jramonfernandez: La dexametasona administrada a partir del séptimo día de vida se considera una intervención eficaz y segura para reduc…
RT @jramonfernandez: La dexametasona administrada a partir del séptimo día de vida se considera una intervención eficaz y segura para reduc…
RT @jramonfernandez: La dexametasona administrada a partir del séptimo día de vida se considera una intervención eficaz y segura para reduc…
RT @jramonfernandez: La dexametasona administrada a partir del séptimo día de vida se considera una intervención eficaz y segura para reduc…
La dexametasona administrada a partir del séptimo día de vida se considera una intervención eficaz y segura para reducir el riesgo de displasia broncopulmonar en prematuros con un perfil de alto riesgo. #Neotwitter #EBNEO
RT @drbretty: “Endotracheal instillation of budesonide with surfactant likely has a beneficial effect on death or BPD at 36 weeks' PMA (RR…
RT @EPIQ_LHG: EPIQ Lung Health Group Article of the month: Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia:…
Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews #neoTwitter https://t.co/Gqo0FuNpcq
“Endotracheal instillation of budesonide with surfactant likely has a beneficial effect on death or BPD at 36 weeks' PMA (RR 0.60, 95% CI 0.49-0.74; NNTB 4, 95% CI 3 to 6; moderate‐certainty evidence)” @PlussTrial 👀 @PASMeeting https://t.co/VYfeAyD
EPIQ Lung Health Group Article of the month: Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews - van de Loo, M - 2024 | Cochrane Library https://t.co/tXu7PXJDcL
RT @CochraneNeonate: Late systemic administration of dexam. is considered an effective intervention to reduce the risk of BPD in infants wi…
RT @CochraneNeonate: Late systemic administration of dexam. is considered an effective intervention to reduce the risk of BPD in infants wi…
RT @CochraneNeonate: Late systemic administration of dexam. is considered an effective intervention to reduce the risk of BPD in infants wi…
RT @CochraneNeonate: Late systemic administration of dexam. is considered an effective intervention to reduce the risk of BPD in infants wi…
@afif_elKhuffash @draloksharma74 @99nicu lol, there is one out now https://t.co/FA3kWXGeFa
Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews April 202 https://t.co/rBozZvf7p0
Budesonide + surfactant instillation and late Dexa >7 days with DART show the most promising results to prevent death and BPD at 36 weeks PMA in infants at most risk of severe lung disease https://t.co/ZbI11gC7l6
RT @CochraneNeonate: Late systemic administration of dexam. is considered an effective intervention to reduce the risk of BPD in infants wi…
RT @CochraneNeonate: Late systemic administration of dexam. is considered an effective intervention to reduce the risk of BPD in infants wi…
RT @CochraneNeonate: Late systemic administration of dexam. is considered an effective intervention to reduce the risk of BPD in infants wi…
Hence, early and accurate prediction of BPD in order to indentify these high-risk patients seems essential
Treatment with dexamethasone after the first week of life may increase babies' survival, decrease BPD, and seems to be safe in babies at high risk of BPD. #neotwitter
RT @CochraneNeonate: Late systemic administration of dexam. is considered an effective intervention to reduce the risk of BPD in infants wi…
Late systemic administration of dexam. is considered an effective intervention to reduce the risk of BPD in infants with a high risk profile for BPD. Endotracheal instillation of budesonide with surfactant as a carrier is a promising intervention. https://